MIRM · Mirum Pharmaceuticals, Inc.
The AI's read
The results give Mirum stronger evidence that LIVMARLI can ease itching and reduce bile acids in children with rare liver conditions. Serious health problems occurred among treated patients, but researchers did not link them to the drug and found no new safety concerns. The study included 52 people and does not establish approval or sales.